The risk of invasive Streptococcus pneumoniae infection (primarily bacteraemia and
meningitis) is greatest among the very young and the very old. Persons in certain racial …

Pneumococcal pneumonia (PP) and invasive pneumococcal disease (IPD) are important
causes of morbidity and mortality in seniors worldwide. Incidence rates and serious …

Introduction Streptococcus pneumoniae is a major cause of morbidity and mortality. We
sought to describe the epidemiology of non-invasive and invasive pneumococcal disease in …

The background and the recent clinical trials of the current pneumococcal vaccine,
especially as they pertain to the institutionalized elderly, are described. Previous studies …

Streptococcus pneumoniae is a leading cause of illness and death among the elderly. The
recent emergence of drug-resistant strains has complicated selection of antimicrobial …

The effective prevention of Streptococcus pneumoniae infection has a renewed priority in an
era in which the emergence of antibacterial-resistant strains has the potential to further …

PURPOSE: To study the efficacy of pneumococcal capsular polysaccharide vaccine among
the elderly by use of a population-based intervention in one township, Varkaus, Eastern …

Objectives: To examine the epidemiology of invasive pneumococcal disease in older adults
hospitalized for invasive pneumococcal disease who are living in the community and in long …

Eighty‐nine episodes of pneumococcal bacteremia were reviewed over a 66‐month period
at a Veterans Administration Medical Center. Forty‐one percent of these episodes were …

Benefits from influenza and 23-valent pneumococcal polysaccharide (23vPPV) vaccines
against invasive pneumococcal disease and laboratory confirmed influenza have been well …